CA2443128A1 - Distribution transdermique de pergolide - Google Patents
Distribution transdermique de pergolide Download PDFInfo
- Publication number
- CA2443128A1 CA2443128A1 CA002443128A CA2443128A CA2443128A1 CA 2443128 A1 CA2443128 A1 CA 2443128A1 CA 002443128 A CA002443128 A CA 002443128A CA 2443128 A CA2443128 A CA 2443128A CA 2443128 A1 CA2443128 A1 CA 2443128A1
- Authority
- CA
- Canada
- Prior art keywords
- pergolide
- delivery device
- liquid
- composition
- matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'invention concerne un dispositif de distribution transdermique comprenant une matrice multi-phase dotée d'un élément solide retenant les liquides auquel est associé du pergolide sous forme liquide, p. ex. un dispositif de distribution transdermique comprenant une couche barrière fixée sur une face de la matrice dotée en outre d'une face exposée. Une couche de montage est fixée sur la face exposée et une couche amovible est fixée sur l'autre face de la matrice. L'élément retenant les liquides peut par exemple être une matière absorbante, telle qu'une gaze de fibres naturelles ou synthétiques, un absorbant médical non tissé, une éponge naturelle et une éponge synthétique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28053301P | 2001-03-30 | 2001-03-30 | |
US60/280,533 | 2001-03-30 | ||
PCT/US2002/010057 WO2002078602A2 (fr) | 2001-03-30 | 2002-04-01 | Distribution transdermique de pergolide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2443128A1 true CA2443128A1 (fr) | 2002-10-10 |
Family
ID=23073490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002443128A Abandoned CA2443128A1 (fr) | 2001-03-30 | 2002-04-01 | Distribution transdermique de pergolide |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1385459A2 (fr) |
JP (1) | JP2005506297A (fr) |
CA (1) | CA2443128A1 (fr) |
WO (1) | WO2002078602A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10341317B4 (de) * | 2003-09-03 | 2008-10-23 | Axxonis Pharma Ag | Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid |
US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
TW200514582A (en) * | 2003-10-31 | 2005-05-01 | Hisamitsu Pharmaceutical Co | Transdermal preparation and method for reducing side effect in pergolide therapy |
EP3936133A1 (fr) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Préparations et thérapies de substitution pour hormonothérapie naturelle combinée |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CA2947767A1 (fr) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Formulations d'hormones substitutives combinees naturelles et traitement hormonal substitutif |
WO2015195448A1 (fr) * | 2014-06-18 | 2015-12-23 | Eli Lilly And Company | Formulations transdermiques de pergolide et utilisations de celles-ci |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
US6572879B1 (en) * | 1995-06-07 | 2003-06-03 | Alza Corporation | Formulations for transdermal delivery of pergolide |
-
2002
- 2002-04-01 CA CA002443128A patent/CA2443128A1/fr not_active Abandoned
- 2002-04-01 JP JP2002576871A patent/JP2005506297A/ja active Pending
- 2002-04-01 EP EP02757900A patent/EP1385459A2/fr not_active Withdrawn
- 2002-04-01 WO PCT/US2002/010057 patent/WO2002078602A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002078602A2 (fr) | 2002-10-10 |
WO2002078602A3 (fr) | 2003-02-20 |
EP1385459A2 (fr) | 2004-02-04 |
JP2005506297A (ja) | 2005-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2443128A1 (fr) | Distribution transdermique de pergolide | |
EP2123274B1 (fr) | Composition médicinale pour une absorption transdermique, unité de stockage de la composition médicinale et préparation par absorption transdermique utilisant celle-ci | |
FI82602C (fi) | Foerfarande foer framstaellning av verksamma plaoster. | |
JP5815556B2 (ja) | 非結晶形態のロチゴチンの固体分散体を安定化するためのポリビニルピロリドン | |
JP2716231B2 (ja) | 生理学的活性物質の投与のための吸蔵体 | |
FI100857B (fi) | Menetelmä välineen valmistamiseksi deksmedetomidiniinin transdermaalis ta antamista varten | |
US20170071870A1 (en) | Transdermal Delivery of Cannabidiol with Other Active Moieties Including Cannabinoids | |
KR20160014064A (ko) | 경피 전달 시스템 | |
KR100995696B1 (ko) | 펜타닐 경피 외용 접착제 | |
KR101486599B1 (ko) | 첩부제 | |
WO2002078604A2 (fr) | Administration transcutanee de materiau bioactif | |
US20080113013A1 (en) | Transdermal, Therapeutic System With Activatable Oversaturation and Controlled Permeation Promotion | |
US11173131B2 (en) | Transdermal device including porous microparticles | |
EP1865931B1 (fr) | Timbre transdermique | |
KR101016914B1 (ko) | 향상된 경피 송달 시스템 | |
EP2650019B1 (fr) | Timbre transdermique contenant un antidépresseur noradrénergique et sérotoninergique spécifique | |
US20040120995A1 (en) | Transdermal delivery of pergolide | |
KR20020084161A (ko) | 레리세트론 전달용 경피치료시스템 | |
JP2011116757A (ja) | リセドロネート経皮吸収製剤(2) | |
JP7399633B2 (ja) | 経皮吸収型製剤の製造方法 | |
Kharia et al. | Overview of Transdermal Medicated Patches with its research updates in preceding years | |
SK281626B6 (sk) | Transdermálny terapeutický systém s obsahom estradiolu | |
JP2011116756A (ja) | ビスフォスフォネート経皮吸収製剤(2) | |
EP3810101A1 (fr) | Système thérapeutique transdermique contenant de la rivastigmine | |
KR20180035859A (ko) | 경피 전달 시스템 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |